-+ 0.00%
-+ 0.00%
-+ 0.00%
Calidi Biotherapeutics prices registered direct offering at USD 1.17 a share to raise USD 1.2 million
Share
Listen to the news
Calidi Biotherapeutics prices registered direct offering at USD 1.17 a share to raise USD 1.2 million
  • Calidi Biotherapeutics set a $1.2 million registered direct offering of 1,025,640 common shares priced at $1.17 each.
  • Closing expected around Sept. 18, 2026, subject to customary conditions.
  • Net proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609170910PRIMZONEFULLFEED9828721) on September 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending